CCI clears Piramal Enterprises-Pfizer deal savita thakur thakur21 Sept 2016 12:08 PM ISTNew Delhi : Fair trade regulator CCI has approved Ajay Piramal-led Piramal Enterprises' proposed acquisition of four brands from pharmaceutical major...
Novartis says MS drug cut risk of disability advance in study savita thakur thakur21 Sept 2016 12:07 PM ISTNovartis's investigational multiple sclerosis drug cut the risk of disability progression in patients with a tough to treat form of the disease versus...
FDA Approves Bayer AGs Five year contraceptive, Kyleena savita thakur thakur21 Sept 2016 12:07 PM ISTThe U.S. Food and Drug Administration approved Bayer AG's hormonal contraceptive device, Kyleena, to prevent pregnancy for up to five years, the...
Zydus Cadila partners Takeda for chikungunya vaccine savita thakur thakur21 Sept 2016 12:06 PM ISTNew Delhi : Drug firm Zydus Cadila announced partnership with Japan's Takeda Pharmaceutical Company Ltd to develop vaccine for chikungunya."The...
Novartis intensifies Entresto push with new analysis savita thakur thakur20 Sept 2016 11:09 AM ISTNovartis intensified its bid to convince doctors to prescribe its heart failure drug Entresto, releasing an analysis that concluded the medicine...
Biocon appoints Suresh Subramanian as Head of Branded Formulations India Business savita thakur thakur20 Sept 2016 11:08 AM ISTMumbai : Biocon Ltd, Asia's premier bio pharmaceuticals company, announced that Suresh Subramanian has been appointed as Head of the Company's Branded...
GE brings off the shelf biotech drug factories to Ireland savita thakur thakur20 Sept 2016 11:07 AM ISTLondon : General Electric is digging deeper into biotechnology with plans to build four prefabricated drug factories in Ireland, bringing to Europe a...
Valeant says discount program for heart drugs on track savita thakur thakur19 Sept 2016 1:56 PM ISTValeant Pharmaceuticals International Inc said its discount and rebates program for two high-priced heart drugs would cover over 90 percent U.S....
EMA panel recommends nod for Pfizers breast cancer drug, Ibrance savita thakur thakur19 Sept 2016 1:30 PM ISTU.S. drugmaker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency...
Johnson n Johnson to buy Abbotts vision unit for 4.33 billion dollars savita thakur thakur18 Sept 2016 9:39 AM ISTJohnson & Johnson said that it is paying more than $4.3 billion in cash to buy the eye health unit of Abbott Laboratories as it seeks to boost its...
Dr Reddy Labs inks pact with Amgen to market three drugs in India savita thakur thakur18 Sept 2016 9:34 AM ISTHyderabad : Dr Reddy's Laboratories (DRL) has expanded its strategic collaboration with US based independent biotechnology firm Amgen to market and...
Natco to file over 10 ANDAs in US in next 2 fiscals savita thakur thakur18 Sept 2016 9:34 AM ISTNew Delhi : Drug firm Natco Pharma is aiming to file over 10 Abbreviated New Drug Applications (ANDAs) in the US in the next two financial years to...
